<span item_type="fundamental" item_id="2821fcd9be28a69ed8295f147f0cae72" counter_id="ST/US/AFJK" env="prod"></span><span item_type="announcement" item_id="584246473734819329" env="prod"></span><p>Revenue: As of FY2025 Q3, the actual value is USD 0.</p><p>EPS: As of FY2025 Q3, the actual value is USD 0.06.</p><p>EBIT: As of FY2025 Q3, the actual value is USD -612.32 K.</p><p></p><h3>Financial Metrics by Segment</h3><h4>Segment Revenue</h4><ul><li>No revenue generated as of September 30, 2025, since the company has not commenced operations and is focused on identifying a target for a business combination.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1979005/000149315225024062/form10-q.htm"></span></li></ul><h4>Operational Metrics</h4><ul><li><strong>Net Income</strong>: $961,651 for the nine months ended September 30, 2025, compared to $2,108,102 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1979005/000149315225024062/form10-q.htm"></span></li><li><strong>Formation and Operating Costs</strong>: $585,170 for the nine months ended September 30, 2025, compared to $662,765 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1979005/000149315225024062/form10-q.htm"></span></li><li><strong>Interest Income</strong>: $1,546,821 for the nine months ended September 30, 2025, compared to $2,770,867 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1979005/000149315225024062/form10-q.htm"></span></li></ul><h4>Cash Flow</h4><ul><li><strong>Net Cash Used in Operating Activities</strong>: - $521,868 for the nine months ended September 30, 2025, compared to - $477,158 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1979005/000149315225024062/form10-q.htm"></span></li><li><strong>Net Cash Provided by Investing Activities</strong>: $29,887,800 for the nine months ended September 30, 2025, compared to $0 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1979005/000149315225024062/form10-q.htm"></span></li><li><strong>Net Cash Used in Financing Activities</strong>: - $29,391,161 for the nine months ended September 30, 2025, compared to $0 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1979005/000149315225024062/form10-q.htm"></span></li></ul><h4>Unique Metrics</h4><ul><li><strong>Cash Held in Trust Account</strong>: $45,443,570 as of September 30, 2025, compared to $73,784,549 as of December 31, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1979005/000149315225024062/form10-q.htm"></span></li><li><strong>Working Capital Deficit</strong>: $2,749,480 as of September 30, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1979005/000149315225024062/form10-q.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><h4>Core Business Focus</h4><ul><li>The company is focused on completing its initial business combination by December 6, 2025, with United Hydrogen Group Inc. as the target.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1979005/000149315225024062/form10-q.htm"></span></li><li>The business combination is expected to close in early 2026, subject to shareholder approvals and regulatory clearances.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1979005/000149315225024062/form10-q.htm"></span></li></ul><h4>Non-Core Business</h4><ul><li>The company has extended the timeframe to complete the business combination twelve times, with the latest extension until December 6, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1979005/000149315225024062/form10-q.htm"></span></li></ul><h4>Priority</h4><ul><li>The company aims to use funds held outside the Trust Account for paying existing accounts payable, identifying and evaluating prospective initial business combination candidates, performing due diligence, and structuring, negotiating, and consummating the business combination.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1979005/000149315225024062/form10-q.htm"></span></li></ul>

Aimei Health Tech | 10-Q: FY2025 Q3 Revenue: USD 0